Results 211 to 220 of about 420,257 (333)

Vision Changes After Head and Neck Cancer Treatment

Head &Neck, Volume 47, Issue 8, Page 2192-2200, August 2025.
ABSTRACT Background Literature about ocular toxicity after head and neck cancer (HNC) treatment is scarce. This study aimed to describe visual function and ocular symptoms among HNC patients. Methods The study used a cross‐sectional design. Two surveys, The National Eye Institute Visual Functioning Questionnaire (NEI‐VFQ) and an Ocular Symptom Scale ...
Hsiao‐Lan Wang, Megan Heskett, Peng Li, Laura Dreer, David Vance, Susan McCammon, Kailei Yan, Amanda Elliott   +7 more
wiley   +1 more source

Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Implication of VEGF as a Critical Stimulator [PDF]

, 2008
Peter A. Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, Quan Dong Nguyen, Howard S. Ying, V. Diana, Edward Quinlan, Ingrid Zimmer-Galler, Julia A. Haller, Sharon D. Solomon, Jennifer Sung, Yasmin Hadi, Kashif Janjua, Nida Jawed, David F. Choy, Joseph R. Arron   +15 more
openalex   +1 more source

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.

Ophthalmology (Rochester, Minn.), 2016
J. Wells, A. Glassman, Allison R. Ayala, L. Jampol, N. Bressler, S. Bressler, Alexander J. Brucker, Frederick L. Ferris, G. Robert Hampton, Chirag D. Jhaveri, M. Melia, R. W. Beck   +11 more
semanticscholar   +1 more source

Macrophages: Subtypes, Distribution, Polarization, Immunomodulatory Functions, and Therapeutics

MedComm, Volume 6, Issue 8, August 2025.
Macrophages originate from the yolk sac, fetal liver, and bone marrow, differentiating into two main subtypes: M1‐like (proinflammatory) and M2‐like (anti‐inflammatory). These subtypes exhibit high plasticity, allowing them to transform in response to environmental cues or therapeutic interventions.
Mengyuan Peng, Niannian Li, Hongbo Wang, Yaxu Li, Hui Liu, Yanhua Luo, Bao Lang, Weihang Zhang, Shilong Li, Liujun Tian, Bin Liu   +10 more
wiley   +1 more source

Treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion

Clinical Ophthalmology, 2014
Teruyo Kida, Seita Morishita, Keigo Kakurai, Hiroyuki Suzuki, Hidehiro Oku, Tsunehiko IkedaDepartment of Ophthalmology, Osaka Medical College, Osaka, JapanBackground: We report our findings in three cases of unilateral macular edema associated with ...
Kida T, Morishita S, Kakurai K, Suzuki H, Oku H, Ikeda T   +5 more
doaj  

Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial

JAMA ophthalmology, 2018
N. Bressler, Wesley T Beaulieu, A. Glassman, K. Blinder, S. Bressler, L. Jampol, M. Melia, J. Wells   +7 more
semanticscholar   +1 more source

Long‐term results after sutureless intrascleral fixation of the Carlevale intraocular lens: Changes in scleral pocket thickness over time

Acta Ophthalmologica, Volume 103, Issue 5, Page e290-e297, August 2025.
Abstract Purpose To investigate the long‐term effects and dynamic changes in scleral thickness above the T‐haptic after sutureless scleral‐fixated intraocular lens (sSFIOL) implantation using the FIL‐SFF Carlevale lens. Setting Single‐centre, single‐surgeon, prospective clinical trial, Department of Ophthalmology, Medical University of Vienna, Austria.
Markus Schranz, Ioanna Dimakopoulou, Marcus Lisy, Victor Danzinger, Daniel Schartmüller, Claudette Abela‐Formanek   +5 more
wiley   +1 more source

Three-year outcomes of cystotomy and fibrinogen clot removal for diabetic macular edema with subfoveal cystoid macular edema. [PDF]

Sci Rep
Yamada H, Imai H, Sotani Y, Matsumiya W, Miki A, Kusuhara S, Nakamura M.   +6 more
europepmc   +1 more source

AGREEMENT BETWEEN CLINICIAN AND READING CENTER GRADINGS OF DIABETIC RETINOPATHY SEVERITY LEVEL AT BASELINE IN A PHASE 2 STUDY OF INTRAVITREAL BEVACIZUMAB FOR DIABETIC MACULAR EDEMA [PDF]

, 2008
Ingrid U. Scott, Neil M. Bressler, Susan B. Bressler, David J. Browning, Clement K. Chan, Ronald P. Danis, Matthew D. Davis, Craig Kollman, Haijing Qin   +8 more
openalex   +1 more source

Safety of Proton Pump Inhibitor in Paediatrics: A Study Based on EudraVigilance Data

Fundamental &Clinical Pharmacology, Volume 39, Issue 4, August 2025.
ABSTRACT Background and Objectives Despite limited paediatric approvals, the use of proton pump inhibitors (PPIs) among children has increased in recent years, and concerns have arisen about their safety, including the risk of allergies. To provide additional evidence on the paediatric safety of PPIs, we performed a study on suspected adverse drug ...
Greta Santi Laurini, Victoria Nikitina, Nicola Montanaro, Domenico Motola   +3 more
wiley   +1 more source